BRANČÍKOVÁ, Dagmar, Zdeněk MECHL, Zdeněk ADAM, Eva JANDÁKOVÁ, Zdeněk PAVLOVSKÝ, Vlastimil VÁLEK and Tomáš ANDRAŠINA. Patient with inoperable pheochromocytoma. Current Oncology. Toronto: Multimed INC., 2015, vol. 22, No 3, p. "E216"-"E219", 4 pp. ISSN 1198-0052. Available from: https://dx.doi.org/10.3747/co.22.2324. |
Other formats:
BibTeX
LaTeX
RIS
@article{1306351, author = {Brančíková, Dagmar and Mechl, Zdeněk and Adam, Zdeněk and Jandáková, Eva and Pavlovský, Zdeněk and Válek, Vlastimil and Andrašina, Tomáš}, article_location = {Toronto}, article_number = {3}, doi = {http://dx.doi.org/10.3747/co.22.2324}, keywords = {Pheochromocytoma; chemoembolization; lanreotide}, language = {eng}, issn = {1198-0052}, journal = {Current Oncology}, title = {Patient with inoperable pheochromocytoma}, volume = {22}, year = {2015} }
TY - JOUR ID - 1306351 AU - Brančíková, Dagmar - Mechl, Zdeněk - Adam, Zdeněk - Jandáková, Eva - Pavlovský, Zdeněk - Válek, Vlastimil - Andrašina, Tomáš PY - 2015 TI - Patient with inoperable pheochromocytoma JF - Current Oncology VL - 22 IS - 3 SP - "E216"-"E219" EP - "E216"-"E219" PB - Multimed INC. SN - 11980052 KW - Pheochromocytoma KW - chemoembolization KW - lanreotide N2 - Malignant pheochromocytoma is a tumour with a very low incidence that occurs sporadically or in the presence of multiple endocrine neoplasia. We present the case of a woman with a sporadic occurrence of pheochromocytoma diagnosed in the phase of multiple dissemination in the abdominal cavity and overexpressing adrenaline, noradrenaline, and dopamine. Local transarterial chemoembolization and systemic treatment with lanreotide resulted in a very good response, a decrease in the production of catecholamines for 12 months and a partial decrease for another 8 months, with stabilization of disease determined by imaging. Systemic treatment with tegafur resulted in disease stabilization lasting 50 months, after which the drug was discontinued because of adverse effects. Maintenance therapy with lanreotide continues, and no disease progression has been observed for 4 months. The treatment algorithm for such patients is multidisciplinary and must always take into account the current scope of the disease, intercurrence, and the general condition of the patient. ER -
BRANČÍKOVÁ, Dagmar, Zdeněk MECHL, Zdeněk ADAM, Eva JANDÁKOVÁ, Zdeněk PAVLOVSKÝ, Vlastimil VÁLEK and Tomáš ANDRAŠINA. Patient with inoperable pheochromocytoma. \textit{Current Oncology}. Toronto: Multimed INC., 2015, vol.~22, No~3, p.~''E216''-''E219'', 4 pp. ISSN~1198-0052. Available from: https://dx.doi.org/10.3747/co.22.2324.
|